MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaapos.2008.03.005

Медицинская библиотека · Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2008

Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.

Pediatric Eye Disease Investigator Group, Repka Michael X, Melia B Michele, Beck Roy W, Atkinson C Scott, Chandler Danielle L, Holmes Jonathan M, Khammar Alexander, Morrison David, Quinn Graham E, Silbert David I, Ticho Benjamin H, Wallace David K, Weakley David R

СтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

PURPOSE: To report the outcome of nasolacrimal duct intubation as the primary treatment of congenital nasolacrimal duct obstruction (NLDO) in children younger than 4 years of age.

METHODS

A total of 182 eyes of 139 children receiving intubation with planned tube retention for 2 to 5 months were enrolled in a prospective, nonrandomized observational multicenter study (19 sites). Children were ages 6 months to <45 months at the time of surgery, with no previous nasolacrimal surgical procedures and had at least one of the following clinical signs of NLDO: epiphora, mucous discharge, and/or increased tear lake.

RESULTS

Treatment success was defined as absence of epiphora, mucous discharge, and increased tear lake at the outcome visit, 1 month after tube removal. The surgical outcome was assessed in 150 eyes (82% of cohort). The proportion of eyes treated successfully was 91% (95% CI: 86%-95%). The outcome dye disappearance test was normal in 125 (86%) eyes, indeterminate in 13 (9%), and abnormal in 7 (5%) of the 145 eyes tested. Monocanalicular tubes were used in 74% of cases. The tube was removed before the planned minimum retention time of 2 months in 61 eyes (41%). For 23 eyes, the early removal was attributed to inadvertent displacement by the patient.

CONCLUSIONS

In children 6 months to <45 months of age, nasolacrimal duct intubation in a nonrandomized and noncomparative trial was a successful primary treatment of NLDO in about 90% of cases not lost to follow-up.

Для цитирования: Pediatric Eye Disease Investigator Group, Repka Michael X, Melia B Michele, Beck Roy W, Atkinson C Scott, Chandler Danielle L, Holmes Jonathan M, Khammar Alexander, Morrison David, Quinn Graham E, Silbert David I, Ticho Benjamin H, Wallace David K, Weakley David R. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2008. DOI: 10.1016/j.jaapos.2008.03.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.